SEP 01, 2020 8:00 AM PDT

Single-cell analyses of checkpoint-inhibition-induced myocarditis: implications into mechanisms of severe immune-related adverse events

Speaker
  • Pharm.D., Ph.D. Associate Professor, Departments of Medicine and Pathology, Microbiology and Immunology Vanderbilt University Medical Center
    BIOGRAPHY

Abstract
DATE:  September 1, 2020
TIME:   8:00am PT, 11:00am ET
 
Nearly half of all cancer patients are eligible to receive treatment with immune checkpoint inhibitors (ICI). Thus, preventing, identifying and treating immune-related adverse events (irAEs) are urgent challenges. Myocarditis is an uncommon irAE, affecting <1% of ICI-treated patients, but has a mortality rate of nearly 50%. To study the mechanisms of ICI-myocarditis, we used a mouse model in which a combination of checkpoint gene KO causes premature death due to myocarditis. By flow cytometry, the myocardial immune infiltrate was primarily composed of CD8+ T cells and CD68+ macrophages, akin to subjects with ICI-associated myocarditis, and anti-CD8 depleting antibodies rescued survival. Single-cell RNA-seq of heart tissue identified highly activated, clonal CD8+ T cells. TCR sequencing also demonstrated highly clonal, but private, TCRs in affected mice. Computational analysis revealed high structural similarity in these TCRs, suggestive of similar antigen binding. TCR sequencing of two subjects who died with ICI-myocarditis also showed high clonality in the heart. Antigen discovery efforts are underway to yield new insights into the pathophysiology of this irAE. For Research Use Only. Not for use in diagnostic procedures.
 
Learning Objectives:
  • Immune-related adverse events and myocarditis (case series)
  • Describe murine models that replicate human checkpoint inhibitor-associated myocarditis
  • Describe implementation of single-cell technologies and flow cytometry to evaluate the inflammatory microenvironment in the murine model
 
 
Webinars will be available for unlimited on-demand viewing after live event.

 

LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.


Show Resources
You May Also Like
MAY 11, 2021 10:00 AM PDT
C.E. CREDITS
MAY 11, 2021 10:00 AM PDT
Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
SEP 14, 2021 7:00 AM PDT
C.E. CREDITS
SEP 14, 2021 7:00 AM PDT
Date: September 14, 2021 Time: 7am PDT, 10am EDT, 4pm CEST A conventional thermal cycler has long been a commodity product in the lab and end-point PCR techniques can be completed almost wit...
JUN 09, 2021 7:00 AM PDT
C.E. CREDITS
JUN 09, 2021 7:00 AM PDT
Date: June 9, 2021 Time: 09 June 2021, 7am PDT, 10am EDT, 4pm CEST cells with dramatic implications on the validity of past cell culture related research. The fact that at least 509 cell lin...
SEP 17, 2021 12:00 PM CST
C.E. CREDITS
SEP 17, 2021 12:00 PM CST
Date: September 16, 2021 Time: 9:00pm (PDT), 12:00am (EDT) 3D cellular models like organoids and spheroids offer an opportunity to better understand complex biology in a physiologically rele...
JUL 15, 2021 8:00 AM PDT
C.E. CREDITS
JUL 15, 2021 8:00 AM PDT
Date: July 15, 2021 Time: 8:00am (PDT), 11:00am (EDT) High dimensional full spectrum flow cytometry grants unprecedented access to previously unattainable parameters in cellular biology. Flu...
APR 01, 2021 8:00 AM PDT
C.E. CREDITS
APR 01, 2021 8:00 AM PDT
Date: April 01, 2021 Time: 8:00am (PST), 11:00am (EST) Generating therapeutic antibodies is far more challenging than obtaining antibodies that merely recognize their targets. Engineering po...
Loading Comments...
Show Resources